Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study

NCT00596102 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT00596102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00596102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study
Lead sponsor
Valneva Austria GmbH
Phase
Observational
Overall status
Completed
Start date
October 31, 2005
Completion date
Not reported
Enrollment
3,258 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis